|
CN103655503A
|
|
Merariveron sustained-release tablet and preparation method thereof
|
|
CN103288773A
|
|
Febuxostat metal salt and preparation method thereof
|
|
CN103193659A
|
|
Novel crystal form of (-)-(1R, 2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl) phenol hydrochloride and preparation method thereof
|
|
CN102935078A
|
|
Ibuprofen oral dispersing film agent
|
|
CN102940616A
|
|
Ambroxol hydrochloride oral cavity dispersion membrane agent
|
|
CN102940617A
|
|
Desloratadine oral dispersible film
|
|
CN102146111A
|
|
New dinucleotide compound and preparation method thereof
|
|
CN102247314A
|
|
Oral solid preparation using moxifloxacin as active component
|
|
CN102247379A
|
|
Compound preparation and preparation method thereof
|
|
CN102247313A
|
|
Oral-administration slow release solid preparation by taking Moxifloxacin as active ingredient
|
|
CN101984966A
|
|
New medicinal composition
|
|
CN101984968A
|
|
Preparation method of pharmaceutical preparation of antitumor agent temozolomide
|
|
CN101985457A
|
|
Medicinal salts of cordycepin and preparation method and medicinal application thereof
|
|
CN102000068A
|
|
Pharmaceutical composition containing ramatroban as well as preparation method and application thereof
|
|
CN101984975A
|
|
Medical composition containing cordycepin derivatives
|
|
CN102397351A
|
|
Traditional Chinese medicinal composition for treating insomnia
|
|
CN102372679A
|
|
Febuxostat water-soluble derivative and preparation method thereof
|
|
CN102370618A
|
|
Emulsion containing Temodal, preparation technology thereof and purpose thereof
|
|
CN102370621A
|
|
Solid preparation with cefotiam hexetil as active component
|
|
CN102342906A
|
|
Oral liquid preparation with ethylenediaminetetraacetic acid iron sodium as active component
|
